Skip to main content

Table 5 Agreement between CLART and LA in 401 women with abnormal cytology

From: Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

LA CLART Total
High-risk genotypes Low-risk genotypes No genotypesa
High-risk genotypes 306 12 8 326 (81%)
Low-risk genotypes 5 41 8 54 (13%)
No genotypes a 0 1 20 21 (5%)
Total 311 (78%) 54 (13%) 36 (9%) 401 (100%)
  1. aOr genotypes not detectable by both CLART and LA (CLART: 43, 44, 85, 89; LA: 55, 64, 67, 69, IS39, CP6108).